Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      CGHS medicine supplier SURRENDERS Rs 200 crore black money

      CGHS medicine supplier SURRENDERS Rs 200 crore black money

      Ruby Khatun Khatun11 Nov 2017 12:46 PM IST
      New Delhi: One of the biggest suppliers of medicines to Central Government Health Scheme (CGHS) hospitals "surrendered" Rs 200 crore he allegedly held...
      Aurobindo Pharma Q2 net up 29 percent at Rs 780.97 crore

      Aurobindo Pharma Q2 net up 29 percent at Rs 780.97 crore

      Ruby Khatun Khatun11 Nov 2017 10:47 AM IST
      New Delhi: Drug firm Aurobindo Pharma reported a 28.96 percent rise in its consolidated net profit to Rs 780.97 crore for the September quarter of the...
      Zydus gets regulatory nod to market Lipaglyn in Mexico

      Zydus gets regulatory nod to market Lipaglyn in Mexico

      Ruby Khatun Khatun11 Nov 2017 10:32 AM IST
      New Delhi: Drug firm Zydus said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for...
      Morepen Labs ties up with Vesale Pharma of Belgium

      Morepen Labs ties up with Vesale Pharma of Belgium

      Ruby Khatun Khatun11 Nov 2017 10:32 AM IST
      New Delhi: Morepen Laboratories Ltd. entered into a tie-up with Vesale Pharma International of Belgium to strengthen its position in the Rs. 1000...
      Alkem Labs Q2 Net up 14 percent at Rs 327.44 crore

      Alkem Labs Q2 Net up 14 percent at Rs 327.44 crore

      Ruby Khatun Khatun11 Nov 2017 10:16 AM IST
      New Delhi: Drug firm Alkem Laboratories reported a 13.63 percent rise in consolidated net profit at Rs 327.44 crore for the quarter ended September 30...
      FDA OKs Merck drug that prevents infection post-stem cell transplant

      FDA OKs Merck drug that prevents infection post-stem cell transplant

      Ruby Khatun Khatun11 Nov 2017 10:01 AM IST
      Merck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
      Dynavax hepatitis B vaccine gets FDA nod on third try, shares up

      Dynavax hepatitis B vaccine gets FDA nod on third try, shares up

      Ruby Khatun Khatun11 Nov 2017 9:45 AM IST
      Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie...
      Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales

      Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales

      Ruby Khatun Khatun11 Nov 2017 9:30 AM IST
      Regeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
      Zydus Cadila, Intas Pharma under CDSCO scanner for launching Unapproved drug

      Zydus Cadila, Intas Pharma under CDSCO scanner for launching Unapproved drug

      Ruby Khatun Khatun10 Nov 2017 4:24 PM IST
      New Delhi: The Central Drug Standards Control Organization (CDSCO) has initiated an inquiry against the two domestic drug makers Zydus Cadila and...
      Granules India posts Q2 net profit at Rs 40 crore

      Granules India posts Q2 net profit at Rs 40 crore

      Ruby Khatun Khatun10 Nov 2017 10:47 AM IST
      New Delhi: Pharma company Granules India reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current...
      Piramal group expands healthcare project ASARA

      Piramal group expands healthcare project ASARA

      Ruby Khatun Khatun10 Nov 2017 10:31 AM IST
      Vishakhapatnam: Piramal Swasthya, an initiative under the aegis of Piramal Foundation (the philanthropic arm of the Piramal Group), announced the...
      Novartis takes fight to Pfizers Ibrance with new Kisqali data

      Novartis takes fight to Pfizers Ibrance with new Kisqali data

      Ruby Khatun Khatun10 Nov 2017 10:17 AM IST
      ZURICH: New data from Novartis's breast cancer drug Kisqali underscored its effectiveness in pre-menopausal women, the Swiss drugmaker said, amid...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok